Skip to main content
HR 2325 114th Congress House

To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.

Introduced: May 14, 2015 See on congress.gov
Health Administrative remediesDepartment of Health and Human ServicesExecutive agency funding and structureHealth technology, devices, supplies
More subjectsShow fewer subjects
ManufacturingMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 15, 2015
Referred to the Subcommittee on Health.
May 14, 2015
Introduced in House
May 14, 2015
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 22, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

This bill amends title XVIII (Medicare) of the Social Security Act to direct the Department of Health and Human Services to provide for a pharmaceutical and technology ombudsman within the Centers for Medicare and Medicaid Services.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Republican 1
R
Bilirakis, Gus M.
Florida · May 14, 2015
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2325: To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2325/
MLA
"H.R. 2325: To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2325/.
Bluebook (legal)
H.R. 2325, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2325/.
Markdown link
[H.R. 2325: To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.](https://openamerica.io/bill/114-HR-2325/)
Report a problem